Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Ctr
Duarte, California, United States
- Usc Norrris Cancer Center
Los Angeles, California, United States
- Bay Area Cancer Research Group
Pleasant Hill, California, United States
- Stanford University School of Medicine
Stanford, California, United States
- Emory University
Atlanta, Georgia, United States
- the University of Chicago
Chicago, Illinois, United States
- Inidana Univ Simon Cancer Center
Indianapolis, Indiana, United States
- University of Kansas Cancer Center
Westwood, Kansas, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Mercy Medical Research Center
Springfield, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Cooper Hospital
Camden, New Jersey, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Medical College of South Carolina-Hollings Cancer Ctr
Charleston, South Carolina, United States
- Ut Southwestern Medical Center at Dallas
Dallas, Texas, United States
- Md Anderson
Houston, Texas, United States
- Medical College of Wisconsin-Froedtert Cancer Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Dec 2013
- Primary completion
- 8 Nov 2016
- Completion
- 8 Nov 2016
- Last update posted
- 9 Feb 2021
- Registered enrollment
- 50
- Registry id
- NCT01912274
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.